A Study to Investigate Treatment Patterns and Effectiveness of Tislelizumab in European Patients With Resectable or Advanced Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)
Recruiting now
Conditions studied: Advanced Non-Small Cell Lung Cancer, Extensive-Stage Small Cell Lung Cancer
In brief
The purpose of this study is to collect real-world data on treatment patterns and clinical outcomes in European patients receiving tislelizumab in routine clinical practice
Key facts
- Study ID
- NCT07652736
- Run by
- BeOne Medicines
- People needed
- 440
- Starts
- 2026-06-05
- Expected to finish
- 2030-11-17
- Last updated by the study team
- 2026-06-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Participants are eligible to be included in the study only if they meet all the following criteria:
- Participants or their legal representative must sign written inform consent form (ICF)
- Participants receive tislelizumab as part of routine clinical practice as determined by the treating physician per standard of care and in accordance with the SmPC, within the approved indications in the 4 cohorts described.
- Note: The decision to treat the patient with a tislelizumab-based regimen, as per its authorized indication, must have been made by the treating physician prior to and independent of the patient's consideration for participation in this study.
You may not qualify if…
- Participants are excluded from the study if they meet any of the following criteria:
- Participants who are unable to understand all implications of study participation.
- Participants who have contraindications for treatment with tislelizumab in the investigator's opinion or have any contraindication as listed in the SmPC of tislelizumab.
- Participants who are deemed ineligible according to the investigator's opinion and the SmPC of tislelizumab.
Where it is running
- Hospital General de Segovia — Segovia, Spain (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.